Ortho Biotech's Yondelis In Ovarian Cancer Test Case For Progression Free Survival Endpoint
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Oncologic Drug Advisory Committee also will evaluate the firm's Doxil in combination with docetaxel for locally advanced or metastatic breast cancer.